Gujarat Magazine

Varicose Ulcer Market expected to grow due to increased spending on R&D as well as the introduction of novel therapies

 Breaking News
  • No posts were found

Varicose Ulcer Market expected to grow due to increased spending on R&D as well as the introduction of novel therapies

July 20
20:39 2021
Varicose Ulcer Market expected to grow due to increased spending on R&D as well as the introduction of novel therapies

Varicose Ulcer Market
The dynamics of the Varicose Ulcer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world, and the expected launch of emerging therapies during the forecast period.

DelveInsight’s Varicose Ulcer market report provides a comprehensive understanding of the Varicose Ulcer, historical and forecasted epidemiology, as well as Varicose Ulcer market trends in the 7MM. In order to discover and analyze the market’s underlying potential, the research also looks at current Varicose Ulcer treatment practices/algorithms, market drivers, market barriers, and unmet medical needs.

Key Highlights from the Varicose Ulcer Market Report

  • As per DelveInsight Varicose Ulcer epidemiology insights, the prevalent cases were estimated to be 4,231,024 in the 7MM in 2020 out of which the highest was observed in the US.

  • The highest Varicose Ulcer diagnosed prevalence was observed in the age group of above 70 years in the United States in 2020.

  • Among the EU5 countries, Germany had the highest Varicose Ulcer diagnosed prevalent population while Spain had the least number of cases in 2020.

  • According to DelveInsight, Varicose Ulcer is more common in women as compared to men.

  • Rheacell, a Ticeba subsidiary, is developing Allogeneic ABCB5-positive Stem Cells/ Allo-APZ2-CVU for the treatment of non-healing Chronic Venous ulcers.

  • Amnio Technology received the FDA approval in October 2020 to proceed with a Phase II clinical trial for their amniotic tissue-based product, PalinGen Flow, under an IND application.

  • Other Varicose Ulcer therapies in the pipeline include TTAX01 (Tissue Tech), EscharEx (MediWound), and others.

  • Key pharmaceutical players such as Rheacell, MediWound, PRP Concepts, SerenaGroup, Merakris Therapeutics, Amnio Technology, Tissue Tech, Ilkos Therapeutic, and others are involved in developing treatments for Varicose Ulcer.

For better understanding about the disease request sample @ What is Varicose Ulcer?

The Varicose Ulcer market report covers current treatment practices, emerging drugs, Varicose Ulcer market share of individual therapies, and current and forecasted Varicose Ulcer market Size from 2018 to 2030, segmented into seven major markets.

Varicose Ulcer: Overview

Varicose Ulcer, also known as Venous Ulcer, is a full-thickness skin defect that does not heal on its own and is caused by chronic venous disease. It is a skin defect below the knee that develops as a result of faulty venous valves and lasts for more than six weeks with no propensity to mend after three or more months. As a result, they are also known as leg ulcers, lower limb ulcers, or stasis ulcers.

Varicose Ulcer Epidemiology Segmentation

  • Varicose Ulcer Prevalent Cases

  • Varicose Ulcer Diagnosed Prevalent Cases

  • Varicose Leg Ulcer Diagnosed Prevalent Cases

  • Varicose Ulcer Type-Specific Distribution

  • Varicose Ulcer Gender-Specific Distribution

  • Varicose Ulcer Age-Specific Distribution

Varicose Ulcer Treatment Landscape

The current Varicose Ulcer treatment includes Conservative Management, Mechanical Treatment, Medications and Surgical options. Treatment must be multidisciplinary and individualized based on the patient’s and illness’s characteristics. Compression therapy, which includes compression stockings and bandages, is the standard of care for Varicose Ulcer.

Pentoxifylline, Aspirin, and Simvastatin, as well as other antibiotics, antiseptics, and anti-inflammatory drugs, are also used for Varicose Ulcer treatment. Various growth factors are also administered to speed up the wound-healing process in ulcers.

Got queries? How to cure varicose ulcer? Find out @ Varicose Veins Ulcer Treatment

Varicose Ulcer Market

  • The market size of Varicose Ulcer was estimated to be USD 1, 626.4 million in 7MM in 2020.

  • The United States accounted for the largest Varicose Ulcer market size as compared to EU5 and Japan in 2020.

  • Among the EU5 countries, Germany had the highest Varicose Ulcer market share while Spain captured the lowest Varicose Ulcer market size in 2020.

Varicose Ulcer Pipeline Therapies and Key Companies

  • Allo-APZ2-CVU: Rheacell

  • EscharEx: MediWound

  • TTAX01: Tissue Tech

Varicose Ulcer Market Drivers

  • Opportunity for emerging therapies due to low competition

  • Easy access to treatment

  • Availability of cost-effective care

Varicose Ulcer Market Barriers

  • Non-adherence to treatment

  • One-size-fit for all approach

  • Lack of services/education in place to monitor patients with a healed venous leg ulcer

Scope for the Report

Coverage: 7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)

Study Period: 2018-30

Varicose Ulcer Key Companies: Rheacell, MediWound, PRP Concepts, SerenaGroup, Merakris Therapeutics, Amnio Technology, Tissue Tech, Ilkos Therapeutic, among others. 

Varicose Ulcer Key Pipeline Therapies: Allo-APZ2-CVU, EscharEx, TTAX01, and others.

Varicose Ulcer Segmentation: By Geography, By Varicose Ulcer therapies

Analysis: Comparative and conjoint analysis of Varicose Ulcer emerging therapies

Tools Used: SWOT Analysis

Case Studies

KOL’s Views

Analyst’s Views

Table of Contents

1.

Key Insights

2.

Executive Summary

3.

SWOT Analysis

4.

Varicose Ulcer Market Overview at a Glance

5.

Disease Background and Overview: Varicose Ulcer

6.

Recognized Establishments

7.

Varicose Ulcer Treatment

8.

Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology (2019)

9.

Evidence‐based (S3) guidelines for diagnostics and treatment of Venous Leg Ulcers- European Dermatology Forum (2016)

10.

Wound healing society – Guidelines for Venous Ulcers (2015)

11.

Varicose Ulcer Epidemiology and Patient Population

12.

7MM Epidemiology of Varicose Ulcer

13.

Varicose Ulcer Unmet Needs

14.

Varicose Ulcer Emerging Drugs

15.

Varicose Ulcer Market Access and Reimbursement

16.

Varicose Ulcer: Seven Major Market Analysis

17.

Case Reports

18.

Varicose Ulcer Market Drivers

19.

Varicose Ulcer Market Barriers

20.

KOL Reviews

21.

Appendix

22.

DelveInsight Capabilities

23.

Disclaimer

24.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

Related Reports

Chronic Venous Ulceration Market

Get comprehensive historical and forecast analysis of Chronic Venous Ulceration Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Array Biopharma, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly, Taiho Oncology, G1 Therapeutics, AB Science, Eisai, Seagen, Effector Therapeutics, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/haridwartoday/gujaratmagazine.in/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share